Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
data monitoring committee
Biotech
After 3rd phase 3 strike, Relmada's depression drug is out
The biotech is looking into a broad range of paths forward, including a merger or reverse merger, buying or selling assets, or selling the company.
Darren Incorvaia
Dec 9, 2024 2:30pm
GSK, Vir hit as COVID-19 drug hopeful halted on weak efficacy
Mar 3, 2021 9:24am
Chi-Med stops pivotal pancreatic cancer trial upon early success
Jan 21, 2020 8:30am
Icon to employ AG Mednet’s cloud-based adjudication software
Jun 12, 2018 2:08pm
UPDATED: Daiichi’s ‘breakthrough’ PhIII trial suspended to new patients
Oct 19, 2016 4:39am
